Bile acid signaling in metabolic disease and drug therapy

Cites (435)

Items 401–435 of 435

1. Na(+)-dependent bile acid transport by hepatocytes is mediated by a protein similar to microsomal epoxide hydrolase
   Patricia von Dippe, Mehran Amoui, C. Alves · 1993 · American Journal of Physiology-Gastrointestinal and Liver Physiology
2. Disturbances in the murine hepatic circadian clock in alcohol-induced hepatic steatosis
   Peng Zhou, Ruth Ann Ross, Cameron M. Pywell, Suthat Liangpunsakul, Giles E. Duffield · 2014 · Scientific Reports
3. Increased Production of Apolipoprotein B-containing Lipoproteins in the Absence of Hyperlipidemia in Transgenic Mice Expressing Cholesterol 7α-Hydroxylase
   Jon H. Miyake, Xuan-Dao T. Doung, William M. Strauss, Gina L. Moore, Lawrence W. Castellani, Linda K. Curtiss, John M. Taylor, Roger A. Davis · 2001 · Journal of Biological Chemistry
4. Modulation of Bile Acid Metabolism by 1α-Hydroxyvitamin D3 Administration in Mice
   Shigeru Nishida, Jun Ozeki, Makoto Makishima · 2009 · Drug Metabolism and Disposition
5. Inhibition of human m-epoxide hydrolase gene expression in a case of hypercholanemia
   Qin‐shi Zhu, Wenxue Xing, Bin Qian · 2003 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
6. Constitutive androstane receptor activation stimulates faecal bile acid excretion and reverse cholesterol transport in mice
   Anne-Laure Sberna, Mahfoud Assem, Thomas Gautier, Jacques Grober, Boris Guiu, Aline Jeannin, Jean-Paul Paı̈s de Barros, Anne Athias, Laurent Lagrost, David Masson · 2010 · Journal of Hepatology
7. Glucose-lowering effects of intestinal bile acid sequestration through enhancement of splanchnic glucose utilization
   Janne Prawitt, Sandrine Caron, Bart Staels · 2014 · Trends in Endocrinology and Metabolism
8. Enterobacteria Modulate Intestinal Bile Acid Transport and Homeostasis through Apical Sodium-Dependent Bile Acid Transporter (SLC10A2) Expression
   Masaaki Miyata, Hiroki Yamakawa, Mayumi Hamatsu, Hideaki Kuribayashi, Yuki Takamatsu, Yasushi Yamazoe · 2010 · Journal of Pharmacology and Experimental Therapeutics
9. Circadian Rhythms in Liver Physiology and Liver Diseases
   Xin Tong, Lei Yin · 2013 · Comprehensive physiology
10. Farnesoid X Receptor: From Medicinal Chemistry To Clinical Applications
    Stefano Fiorucci, Andrea Mencarelli, Elenora Distrutti, Angela Zampella · 2012 · Future Medicinal Chemistry
11. Metformin and its Liver Targets in the Treatment of Type 2 Diabetes
    J. Radziuk, Clifford J. Bailey, Nicolas F. Wiernsperger, John S Yudkin · 2003 · Current Drug Targets - Immune Endocrine & Metabolic Disorders
12. Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage
    Fan Lian, Xiangbin Xing, Gang Yuan, Claus Schäfer, Sandra Rauser, Axel Karl Walch, Christoph Röcken, Martin Ebeling, Matthew B. Wright, Roland Michael Schmid et al. · 2011 · Biochemical Journal
13. Constitutive androstane receptor mediates the induction of drug metabolism in mouse models of type 1 diabetes†
    Bingning Dong, Mohammed Qatanani, David D. Moore · 2009 · Hepatology
14. The farnesoid X receptor: a novel drug target?
    Thierry Claudel, Ekkehard Sturm, Folkert Kuipers, Bart Staels · 2004 · Expert Opinion on Investigational Drugs
15. Role of Nuclear Receptors in Lipid Dysfunction and Obesity-Related Diseases
    Hollie I. Swanson, Taira Wada, Wen Xie, Barbara Renga, Angela Zampella, Eleonora Distrutti, Stefano Fiorucci, Bo Kong, Ann Thomas, Grace Liejun Guo et al. · 2012 · Drug Metabolism and Disposition
16. Diurnal rhythms of bile acid production in the rat
    W C Duane, Mark L. Gilberstadt, Dorothy M. Wiegand · 1979 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
17. Modulation of Hepatocyte Apoptosis: Cross-talk Between Bile Acids and Nuclear Steroid Receptors
    Bentham Science Publisher Bentham Science Publisher · 2006 · Current Medicinal Chemistry
18. Effect of chronic ethanol exposure on the liver of Clock-mutant mice
    Takashi Kudo, Toru Tamagawa, Shigenobu Shibata · 2009 · Journal of Circadian Rhythms
19. Circadian events in human diseases and in cytochrome P450‐related drug metabolism and therapy
    Rok Košir, Klemen Španinger, Damjana Rozman · 2013 · IUBMB Life
20. Alteration in lipoprotein lipase activity bound to triglyceride-rich lipoproteins in the postprandial state in type 2 diabetes
    Valérie Pruneta‐Deloche, Agnès Sassolas, Geesje M. Dallinga‐Thie, François Berthézène, Gabriel Ponsin, Philippe Moulin · 2004 · Journal of Lipid Research
21. Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders
    Csako, Gyorgy, McGriff, Nayahmka J, Rotman-Pikielny, Pnina, Sarlis, Nicholas J, Pucino, Frank · 2001 · Annals of Pharmacotherapy
22. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis
    Yaping Liu, Jane G. Binz, Mary Jo Numerick et al. · 2003 · Journal of Clinical Investigation
23. Effects of Restricted Feeding on Daily Fluctuations of Hepatic Functions Including P450 Monooxygenase Activities in Rats
    Jun Hirao, Shingo Arakawa, Kyoko Watanabe · 2005 · Journal of Biological Chemistry
24. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element
    Thierry Claudel, Ekkehard Sturm, Hélène Duez, Inès Pineda‐Torra, Audrey Sirvent, Vladimir Kosykh, Jean‐Charles Fruchart, Jean Dallongeville, Dean W. Hum, Folkert Kuipers et al. · 2002 · Journal of Clinical Investigation
25. Suppression of Bile Acid Synthesis, But Not of Hepatic Cholesterol 7α–Hydroxylase Expression, by Obstructive Cholestasis in Humans
    Marco Bertolotti, Lucia Carulli, Mauro Concari, Pietro Martella, Paola Loria, Enrico Tagliafico, Sérgio Ferrari, Marina Del Puppo, Barbara Amati, Emma De Fabiani et al. · 2001 · Hepatology
26. The new therapeutic frontier--nuclear receptors and the liver
    Karpen, Saul J., Trauner, Michael · 2010 · Journal of Hepatology
27. Rifampicin and treatment of cholestatic pruritus
    Alan F. Hofmann · 2002 · Gut
28. Atypical Mechanism of Glucose Modulation by Colesevelam in Patients with Type 2 Diabetes
    Oliseyenum M. Nwose, Michael R. Jones · 2013 · Clinical Medicine Insights Endocrinology and Diabetes
29. Critical role of cholic acid for development of hypercholesterolemia and gallstones in diabetic mice
    Jin Wang, Mats E. Gåfvels, Mats Rudling, Charlotte Murphy, Ingemar Björkhem, Curt Einarsson, Gösta Eggertsen · 2006 · Biochemical and Biophysical Research Communications
30. Treatment with constitutive androstane receptor ligand during pregnancy prevents insulin resistance in offspring from high-fat diet-induced obese pregnant mice
    Hisashi Masuyama, Yuji Hiramatsu · 2012 · American Journal of Physiology-Endocrinology and Metabolism
31. Phenobarbital treatment enhances insulin mediated glucose metabolism in man.
    Jorma T. Lahtela, P Särkkä, Eero A. Sotaniemi · 1984 · PubMed
32. Effects of pregnenolone‐16α‐carbonitrile on the metabolism of cholesterol in rat liver microsomes
    Dagny Ståhlberg · 1995 · Lipids
33. Bile synthesis in rat models of inflammatory bowel diseases
    Nektarios Dikopoulos, Roland M. Schmid, Max Georg Bachem · 2007 · European Journal of Clinical Investigation
34. PRESENCE OF A DIURNAL RHYTHM
    William Duane, David G. Levitt, Susan M. Mueller, J C Behrens · 1983
35. Announcements
    1998 · Journal of Hepatology